Bob Jahr
President and Chief Executive Officer
Replay available
Outlook Therapeutics, Inc. (OTLK) Q3 2026 Earnings Call
Outlook Therapeutics, Inc. (NASDAQ: OTLK) Q3 2026 earnings conference call, held 2026-08-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Lawrence Kenyon
Executive Vice President and Chief Financial Officer
Julian Harrison
Analyst, BTIG
Kemp Dolliver
Analyst, Brookline Capital Markets
Douglas Salmon
Analyst, H.C. Wainwright
Ed Wu
Analyst, Acadian Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Outlook Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.974 Hello everyone and welcome to the Outlook Therapeutics third quarter fiscal year 2026 00:00:04.974 -- 00:00:07.816 corporate update conference call and webcast. 00:00:07.816 -- 00:00:11.798 As a brief reminder, all participants are currently in a listen-only mode. 00:00:11.798 -- 00:00:15.501 If anyone requires operator assistance during the event, please press star zero on your 00:00:15.501 -- 00:00:20.344 telephone keypad. Following the presentation, there will be a question and answer session. 00:00:20.344 -- 00:00:24.567 Note that this webcast is being recorded and a replay will be made available on the company's 00:00:24.567 -- 00:00:29.705 website following the end of the event. At this time, I'd like to remind our listeners 00:00:29.705 -- 00:00:35.209 that remarks made during this webcast may state management's intentions, beliefs, expectations, 00:00:35.209 -- 00:00:39.592 plans, or future projections. These are forward-looking statements and involve risk and 00:00:39.592 -- 00:00:41.592 uncertainties. 00:00:53.807 -- 00:00:58.188 As a result, you should not place undue reliance on any forward-looking statements, some 00:00:58.188 -- 00:01:03.989 of the factors that could cause actual results different materially from those contemplated 00:01:03.989 -- 00:01:08.250 by such forward-looking statements and discussed in the periodic reports Outlook Therapeutics 00:01:08.250 -- 00:01:11.110 files and Securities and Exchange Commissions. 00:01:11.110 -- 00:01:15.771 These documents are available in the investor sections of the company's website and on 00:01:15.771 -- 00:01:18.892 the Security Exchange Commission's website. 00:01:18.892 -- 00:01:23.599 We encourage you to review these documents carefully Additionally, certain inf...